Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 08/31 04:00:00 pm
31.97 USD   -2.32%
05:35pDJCBO finds patent-law change could cost health programs $1.3 billi..
08/25DJU.S. HOT STOCKS : Hot Stocks to Watch
08/24DJAcorda Therapeutics Shares Surge
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2015 08/26/2015 08/27/2015 08/28/2015 08/31/2015 Date
31.37(c) 31.96(c) 31.69(c) 32.73(c) 31.97(c) Last
5 449 511 1 399 932 1 105 919 1 074 544 891 818 Volume
+8.32% +1.88% -0.84% +3.28% -2.32% Change
More quotes
Financials ($)
Sales 2015 452 M
EBIT 2015 -9,58 M
Net income 2015 -17,2 M
Finance 2015 14,4 M
Yield 2015 -
Sales 2016 505 M
EBIT 2016 -4,14 M
Net income 2016 -19,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,07x
Capi. / Sales 2016 2,78x
Capitalization 1 402 M
More Financials
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
05:35pDJCBO finds patent-law change could cost health programs $1.3 billion
08/25DJU.S. HOT STOCKS : Hot Stocks to Watch
08/25 ACORDA THERAPEUTICS : Other Events, Financial Statements and Exhibits (form 8-K)
08/24DJAcorda Therapeutics Shares Surge
08/24DJAcorda Therapeutics Shares Surge After Denial of Patent Challenge--Update
08/24 ACORDA THERAPEUTICS : Announces Patent Trials and Appeal Board (PTAB) Denies Bot..
08/20 ACORDA THERAPEUTICS : Patent Issued for Compositions and Methods of Using Chondr..
08/12 ACORDA THERAPEUTICS : to Present at the Canaccord Genuity Growth Conference
More news
Sector news : Bio Therapeutic Drugs
11:06a GENMAB A/S : Total Number of Voting Rights and Total Share Capital
07:50a MEDICINES : shares surge on upbeat cholesterol drug study
07:01a INTREXON : Soligenix Announces Completion of Patient Enrollment into its Phase 2..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
11:55a Approval Of Repatha May Give Amgen A $5B Boost.
08/26 Kyle Bass's Latest IPR Missile Ventures Into Biologics And Threatens Amgen's ..
08/25 No one loses in premarket today
08/25 PREMARKET BIOTECH DIGEST : SA Author On Valeant, Stocks Tumble, Novartis Promact..
08/24 After Hours Gainers / Losers


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions